Citation Impact
Citing Papers
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients
2007 StandoutNobel
The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation.
1995
The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions.
1998
Inflammation and cancer
2002 StandoutNature
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
Chemokines and leukocyte traffic
1998 StandoutNature
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
Genetic analysis of resistance to viral infection
2007 StandoutNobel
Pathogenesis and therapy of psoriasis
2007 StandoutNature
Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants
2006
Defining protective responses to pathogens: cytokine profiles in leprosy lesions
1991 StandoutScience
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
1996 StandoutNature
Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions
2012
Immunopathogenesis of psoriasis
2007
Colony-stimulating factors in inflammation and autoimmunity
2008
The Burden of Respiratory Syncytial Virus Infection in Young Children
2009 Standout
Differential TNFα mRNA regulation detected in the epidermis of leprosy patients
2002
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
1997 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Psoriasis
2015 Standout
Interleukin-10-deficient mice develop chronic enterocolitis
1993 Standout
Psoriasis: emerging therapeutic strategies
2005
Role of growth factors in inflammation and repair
1989
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
1995
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function
2001 StandoutNobel
The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions
1997
Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-α monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris
2003
Protective and Damaging Effects of Stress Mediators
1998 Standout
Gamma interferon, cytokine-induced macrophage activation, and antimicrobial host defense in vitro, in animal models, and in humans
1990
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
1993
Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells
1999
A Membrane-proximal Basic Domain and Cysteine Cluster in the C-terminal Tail of CCR5 Constitute a Bipartite Motif Critical for Cell Surface Expression
2001 StandoutNobel
Combined Multidrug andMycobacterium wVaccine Therapy in Patients with Multibacillary Leprosy
1993
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
1999 StandoutNature
Evidence for In Vivo Generation of Cytotoxic T Cells: PPD-stimulated Lymphocytes from Tuberculous Pleural Effusions Demonstrate Enhanced Cytotoxicity with Accelerated Kinetics of Induction
1992
Immunopathology of RSV infection: prospects for developing vaccines without this complication
2006
Inflammation in atherosclerosis
2002 StandoutNature
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
2006 Standout
Respiratory syncytial virus infection: therapy and prevention
2004
Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis
2001
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
2002 StandoutNature
Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses
1998
Cytokine Signaling in 2002
2002 Standout
Points of control in inflammation
2002 StandoutNature
Recent Advances in Cytokine Therapy in Leprosy
1993
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
1996 StandoutNature
Mycobacterial‐induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients
1990
β-Arrestin-2 regulates the development of allergic asthma
2003 StandoutNobel
Interferon-Induced Proteins and the Antiviral State
1990
SARS-CoV-2 vaccines in development
2020 StandoutNature
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
An In Vitro Model for the Lepromatous Leprosy Granuloma: Fate ofMycobacterium lepraefrom Target Macrophages after Interaction with Normal and Activated Effector Macrophages
2004
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
1994 Standout
Mig and IP-10: CXC chemokines that target lymphocytes
1997
Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus
2001
Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
1993 Standout
Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1.
1996
Proliferating dendritic cell progenitors in human blood.
1994 StandoutNobel
Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization.
1989
Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells
1995 StandoutScience
Functional Role of Type I and Type II Interferons in Antiviral Defense
1994 StandoutScience
Synergistic Effects of Epidermal Growth Factor (EGF) and Insulin-Like Growth Factor I/Somatomedin C (IGF-I) on Keratinocyte Proliferation May Be Mediated by IGF-I Transmodulation of the EGF Receptor
1991
Early molecular events in the induction phase of contact sensitivity.
1992
CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.
1996 Standout
Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients.
1992
Early gamma interferon mRNA expression is associated with resistance of mice against Yersinia enterocolitica
1994
PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy.
1994
Zanvil Alexander Cohn 1926-1993.
1994 StandoutNobel
Migration and Differentiation of Autoreactive B-1 Cells Induced by Activated γ/δ T Cells in Antierythrocyte Immunoglobulin Transgenic Mice
2000 StandoutNobel
Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2
1997 StandoutNobel
Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells.
1993
Inflammation and Atherosclerosis
2002 Standout
Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
2005 StandoutNobel
Human Chemokines: An Update
1997 Standout
Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).
1987
Tuberculosis: Commentary on a Reemergent Killer
1992 StandoutScience
IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.
1993
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis
2001
Expression of CC and CXC chemokines and chemokine receptors in human leprosy skin lesions
2003
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
1989 StandoutScience
Signal Sequence Trap: a Cloning Strategy for Secreted Proteins and Type I Membrane Proteins
1993 StandoutScienceNobel
Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines
1989
β-Arrestin-2 regulates the development of allergic asthma
2003 StandoutNobel
Human Mycobacterium tuberculosis-reactive CD4+ T-cell clones: heterogeneity in antigen recognition, cytokine production, and cytotoxicity for mononuclear phagocytes
1991
Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes
1998
Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques.
1988
Addition of immunotherapy with Mycobacterium w vaccine to multi-drug therapy benefits multibacillary leprosy patients
1995
Novel responses of human skin to intradermal recombinant granulocyte/macrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing.
1992
The Role of Chemokine Receptors in Primary, Effector, and Memory Immune Responses
2000
The Pten/PI3K pathway governs the homeostasis of Vα14iNKT cells
2006 StandoutNobel
Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes.
1996
Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity
2005 StandoutNobel
The Continuing Challenges of Leprosy
2006 Standout
Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes.
1989 Standout
Effect of multiple interferon gamma injections on the disposal of Mycobacterium leprae.
1989
Mycobacterium leprae renders Schwann cells and mononuclear phagocytes susceptible or resistant to killer cells
1991
Works of Gerald E. Hancock being referenced
The Immunogenicity of Subunit Vaccines for Respiratory Syncytial Virus after Co-formulation with Aluminum Hydroxide Adjuvant and Recombinant Interleukin-12
2000
Formulation of the purified fusion protein of respiratory syncytial virus with the saponin QS-21 induces protective immune responses in mice that are similar to those generated by experimental infection
1995
Intradermal Recombinant Interleukin 2 Enhances Peripheral Blood T‐Cell Responses to Mitogen and Antigens in Patients with Lepromatous Leprosy
1990
CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV)
2001
In vivo administration of low-dose human interleukin-2 induces lymphokine-activated killer cells for enhanced cytolysis in vitro
1991
The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin.
1987
Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H
2000
Characterization of Recombinant Respiratory Syncytial Viruses with the Region Responsible for Type 2 T-Cell Responses and Pulmonary Eosinophilia Deleted from the Attachment (G) Protein
2004
Keratinocyte growth regulation by the products of immune cells.
1988
Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus
1996
The generation of antigen-specific, major histocompatibility complex-restricted cytotoxic T lymphocytes of the CD4+ phenotype. Enhancement by the cutaneous administration of interleukin 2.
1989
Multigenic control of resistance to Yersinia enterocolitica in inbred strains of mice
1988
The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin 2.
1989
The systemic influence of recombinant interleukin 2 on the manifestations of lepromatous leprosy.
1991
Yersinia enterocolitica infection in resistant and susceptible strains of mice
1986
B-cell depletion inhibits arthritis in a collagen-induced arthritis (CIA) model, but does not adversely affect humoral responses in a respiratory syncytial virus (RSV) vaccination model
2005